Hyperliquid Strategies (NASDAQ:PURR) Given “Buy” Rating at Chardan Capital

Chardan Capital reiterated their buy rating on shares of Hyperliquid Strategies (NASDAQ:PURR) in a report released on Friday,Benzinga reports. They currently have a $9.75 price objective on the stock.

Several other research firms have also issued reports on PURR. Maxim Group started coverage on Hyperliquid Strategies in a report on Friday, April 24th. They set a “buy” rating and a $10.00 price target for the company. Cantor Fitzgerald boosted their price target on Hyperliquid Strategies from $6.00 to $8.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Wall Street Zen raised Hyperliquid Strategies to a “hold” rating in a research note on Saturday, February 21st. Finally, Weiss Ratings raised Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $9.25.

Hyperliquid Strategies Stock Up 2.5%

PURR stock opened at $8.70 on Friday. Hyperliquid Strategies has a 1-year low of $3.01 and a 1-year high of $11.62. The business has a fifty day simple moving average of $7.14. The stock has a market capitalization of $1.26 billion, a PE ratio of -1.18 and a beta of 1.64.

Hyperliquid Strategies (NASDAQ:PURR) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.01 earnings per share for the quarter. The business had revenue of $2.63 million during the quarter. Analysts expect that Hyperliquid Strategies will post -0.75 EPS for the current year.

Institutional Trading of Hyperliquid Strategies

Several hedge funds and other institutional investors have recently bought and sold shares of PURR. Boothbay Fund Management LLC purchased a new stake in shares of Hyperliquid Strategies during the 4th quarter valued at $40,000. XTX Topco Ltd purchased a new position in Hyperliquid Strategies in the 4th quarter worth $48,000. Squarepoint Ops LLC purchased a new position in Hyperliquid Strategies in the 4th quarter worth $73,000. Private Advisor Group LLC purchased a new position in Hyperliquid Strategies in the 1st quarter worth $83,000. Finally, Millennium Management LLC purchased a new position in Hyperliquid Strategies in the 4th quarter worth $87,000. Institutional investors own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.